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Abstract
We have characterized the entry leading to productive infection of a type C FMDV in two cell lines widely used for virus growth, BHK-21 and
IBRS-2. Inhibition of clathrin-mediated endocytosis by sucrose treatment decreased both cell entry and virus multiplication. Evidence of a direct
requirement of clathrin for productive viral entry was obtained using BHK21-tTA/anti-CHC cells, which showed a significant reduction of viral
entry and infection when the synthesis and functionality of clathrin heavy chain was inhibited (Tet− cells). This was also observed for vesicular
stomatitis virus (VSV) productive entry. The effect of NH4Cl and concanamycin A on FMDV entry and infection was consistent with the
requirement of acidic compartments for decapsidation and virus replication. As expected from its higher stability at acidic pH, this requirement was
higher for VSV. Since BHK-21 and IBRS-2 cells expressed caveolin-1, we explored the effect on productive virus entry of drugs that interfere with
caveolae-mediated endocytosis. Treatment with nystatin did not reduce entry and infection of FMDV or VSV, while cholesterol depletion with
MβCD significantly inhibited both steps of the FMDV cycle, indicating that plasma membrane cholesterol is required for virus productive entry.
© 2007 Elsevier Inc. All rights reserved.Introduction
The way in which different viruses can exploit endocytic
pathways to enter susceptible cells is varied and provides of a
useful tool to gain basic information on the molecular
mechanisms involved in membrane traffic in animal cells
(Dimitrov, 2004; Marsh and Helenius, 2006). Although the
clathrin-dependent pathway is the entry route best characterized
for virus entry, alternative, clathrin-independent pathways are
also used. These alternative pathways can be classified into two
major classes: lipid-raft-dependent pathways (including the
caveolar pathway) used by acid-independent viruses, and non-
clathrin, non-caveolae-mediated endocytosis (Marsh and Hele-
nius, 2006; Sieczkarski and Whittaker, 2005).⁎ Corresponding author. CBMSO, Cantoblanco 28049, Madrid, Spain. Fax:
+34 91 4978087.
E-mail address: fsobrino@cbm.uam.es (F. Sobrino).
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doi:10.1016/j.virol.2007.07.021Most viruses do need endocytic internalization for penetra-
tion and productive infection. A dependence on low pH for
penetration drives viruses to use the decreasing pH of endocytic
organelles as a cue to activate the penetration reactions and
allows viral escape to the cytoplasm at specific locations before
the virus is delivered to the hydrolytic lysosomes. In addition,
no viral components remain on the cell surface after penetration
for detection by host immune defences (Smith and Helenius,
2004). However, viruses that do not require low pH for
penetration can be found in different families of non-enveloped
viruses, including Picornaviruses, such as some enteroviruses
(Pietiainen et al., 2004). Moreover, it has been proposed that
some enteroviruses, such as poliovirus (PV), may penetrate
directly through the plasma membrane, though this remains
contentious (Bubeck et al., 2005; Hogle, 2002).
The Picornaviridae family comprises a wide number of
important human and animal pathogens. In spite of their close
structural relationships, different members of this family can
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Kirchhausen, 1998; Joki-Korpela et al., 2001; Marjomaki
et al., 2002; Snyers et al., 2003; Stuart et al., 2002).
Picornaviruses are known to undergo structural alterations
during receptor interactions and entry, leading to the uncoating
of the virus particle and release of the viral genome into the
cytoplasm. This is required for subsequent translation and
replication events (Hogle, 2002). pH stability of different
Picornaviruses could be very important for uncoating. The
acidic pH environment of endosomes or their rupture has been
proposed as the mechanisms utilized by pH-sensitive virus
(Huber et al., 2001; Schober et al., 1998), while uncoating of
acid pH-stable virus takes place in other organelles (Pietiainen
et al., 2004).
Foot-and-mouth disease virus (FMDV) is the prototype
member of the aphthovirus genus within the family Picornavir-
idae (Rowlands, 2003; Sobrino and D.E., 2004). The virus
causes a vesicular disease of cloven-hoofed animals that
produces high losses in livestock production and trading
(Sutmoller et al., 2003). FMDV exhibits a high genetic and
antigenic variability, which is reflected in seven serotypes and
multiple variants, that endows this virus with a high potential
for adaptation (Domingo et al., 2003). FMDV particles are
composed of a non-enveloped capsid containing a linear plus
strand RNA genome about 8.500 nucleotides long. This RNA
encodes a single polyprotein, which is expressed and cleavaged
in infected cells to render capsid proteins (VP1 to 4) as well as
15 different mature non-structural proteins (Belsham, 2005).
FMDV can initiate infection of cultured cells via different αv
integrins (Berinstein et al., 1995; Jackson et al., 2004; Jackson
et al., 2002; Jackson et al., 2000). Viruses that are infectious in
vivo can enter cultured cells using αvβ3 and αvβ6 integrins
(Jackson et al., 2000; Neff et al., 1998). This latter integrin is
expressed constitutively on the epithelial cells targeted by
FMDV in cattle, and it has been suggested to be the major in
vivo receptor for this virus (Monaghan et al., 2005). Interaction
of FMDV with these integrins requires an Arg-Gly-Asp (RGD)
triplet located at the G-H loop of capsid protein VP1 (Acharya
et al., 1989), which is also a main antigenic site involved in the
interaction with neutralizing antibodies (Hewat et al., 1997;
Mateu, 1995; Verdaguer et al., 1995).
Recent reports have approached the analysis of the early
internalization events mainly by using human cell lines
transfected with or constitutively expressing human integrins
αvβ3 or αvβ6 (Berryman et al., 2005; O'Donnell et al., 2005). In
both cases, the use of specific inhibitors and co-localization
assays with cellular markers indicated that FMDV types A and
O utilize a clathrin-dependent mechanism to infect these cells.
This was further supported by the inhibition of infected cells
observed upon expression of a dominant-negative version of
AP180 that is required for clathrin cage assembly (Berryman
et al., 2005). The infection reduction observed upon treatment
with inhibitors of the early to late endosomal traffic, indicated
also that infection occurred from early endosomes (Berryman
et al., 2005), which is consistent with the high instability of
FMDV capsids at pH below 7 (Curry et al., 1995; van Vlijmen
et al., 1998).In this study, two cell lines (BHK-21 and IBRS-2), widely
used for basic FMDV studies, as well as for vaccine production
and diagnostic purposes (Barteling, 2004; Brown, 1998), have
been used to characterize the requirements for internalization
leading to productive infection of a type C FMDV isolate and of
VSV, a rhabdovirus causing a vesicular animal disease clinically
similar to FMD, whose entry through clathrin-mediated
endocytosis is well characterized (Matlin et al., 1982; Sun et
al., 2005). Evidences are presented on the involvement of
clathrin in productive type C FMDV endocytosis by BHK-21
and IBRS-2 cells, and of the direct requirement of clathrin
heavy chain (CHC) for this process in BHK21-tTA/anti-CHC
cells expressing low levels of a non-functional CHC (Iversen et
al., 2003). In addition, treatment of BHK-21 and IBRS-2 cells
with the cholesterol-depleting drug MβCD has revealed a
dependence on plasma membrane cholesterol for FMDV entry
and growth.
Results
Hypertonic shock inhibits type C FMDV infection in BHK-21
and IBRS-2 cells
Treatment with sucrose has been shown to block uptake and
infection by virus that use clathrin-dependent endocytosis to
entry into cells (Gilbert and Benjamin, 2000; Nicola et al.,
2003) and to inhibit the uptake of type O FMDV isolates in
SW480-αvβ6 cells (Berryman et al., 2005). BHK-21 and IBRS-
2 cells (Fig. S1) treated with 0.45 M sucrose showed a drastic
inhibition of TF internalization, a ligand whose uptake takes
place by clathrin-mediated endocytosis (Sandvig et al., 1987),
as well a reduced entry of type C FMDV in BHK-21 cells,
whose fluorescence appeared mostly distributed at the plasma
membrane (Fig. 1A). This inhibition of FMDV endocytosis
correlated with a decrease in the progress of virus infection in
experiments performed at low MOI, to limit the possibility of
unspecific viral uptakes due to the high amount of virus used in
the internalization assays. Thus, a 65% of plaque reduction was
observed in BHK-21 cells treated with sucrose, relative to
control cells (Fig. 1B). Likewise, detection of infected cells by
immunofluorescence with a MAb to capsid protein VP1 showed
that sucrose treatment significantly reduced the percentage of
BHK-21 and IBRS-2-infected cells by 91% and 81%,
respectively (Fig. 1C). The hypertonic shock inhibited in a
similar amount the total virus yield recovered from BHK-21 or
IBRS-2-infected cultures (Fig. 1C). These decreases in virus-
infected cells and virus production correlated with a reduction
of the amount of capsid protein VP1 detected by western blot of
BHK-21-infected cell extracts (Fig. 1D).
Thus, these results are consistent with the requirement of
clathrin-dependent endocytosis for type C FMDV internaliza-
tion leading to virus growth.
Expression of clathrin is required for FMDV infection
Sucrose treatment might inhibit endocytic pathways other
than the clathrin-dependent (Roseberry and Hosey, 2001).
Fig. 1. Hypertonic medium inhibits FMDV internalization and infection of BHK-21 and IBRS-2 cells. (A) Sucrose treatment inhibits TF endocytosis and FMDV
internalization into BHK-21 cells. Cells, incubated in hypertonic medium for 30 min, were either infected with FMDV (MOI of 35) for 25 min or incubated with Alexa
Fluor 488-labeled TF. Extracellular TF was eliminated by acid wash and FMDV was detected using MAb 5C4 and a secondary antibody coupled to Alexa Fluor 488.
Scale bars 20 μm. (B) FMDV plaque reduction assay in BHK-21 cells. Cells treated, or not, with sucrose were infected with FMDV (50–100 PFU) and the PFU
determined as described in Materials and methods (left). The percentage of PFU recovered is relative to those of observed in untreated control cells. The means and SD
from three independent experiments are shown (right). (C) Sucrose treatment inhibits FMDV infection. Sucrose treated cells were infected with FMDV (MOI of 0.5).
The total virus titer at 8 h PI was determined by plaque assay on BHK-21 cells. Infected cells (6 h PI) were estimated as those positive for immunofluorescence using
MAb SD6 and an Alexa Fluor 488 as secondary antibody. The percentages of virus titers and of immunofluorescent cells are relative to those observed in untreated
control cells. The means and SD from three independent experiments are shown. (D) Hypertonic medium reduces FMDV VP1 expression. BHK-21 cells treated as in
panel C were lysed at 6 h PI and VP1 was detected by western blot assay using MAb SD6. Blotting to an anti-β-actin MAb was included as control of protein loading.
107M.A. Martín-Acebes et al. / Virology 369 (2007) 105–118Therefore, the direct involvement of clathrin in FMDVentry and
virus multiplication was further analyzed by using a BHK-21
derived cell line (BHK21-tTA/antiCHC) stably transfected with
an antisense RNA to the CHC. Transcription of this antisense
RNA from a tetracycline-repressible promoter, not only inhibits
expression of new CHC but induces a lack of functionality in the
previously synthesized CHC molecules (Iversen et al., 2003).
Type C FMDV-infected BHK21-tTA/antiCHC cells grown in
the presence of tetracycline (Tet+). FMDV infection of these
cells did not induce a clear cytopathic effect (data not shown).
However, an increase of virus detection in the infection medium
was found as infection progressed (Fig. 2A). The viral titres
recovered, which ranged from 103 to 104 PFU/ml, were lower
than those found in BHK-21-infected cells. Infection of Tet+
cells with VSV produced cytopathic effect and a parallel kinetic
in virus production was found in the culture medium (Fig. 2A).
This rhabdovirus was chosen as control in these experiments
since its clathrin requirement for cell entry is well established(Sun et al., 2005). In this case, viral titres were higher than those
recovered upon FMDV infection (Fig. 2A).
Removal, of tetracycline from BHK21-tTA/antiCHC culture
medium (Tet−) resulted in about a 70% reduction, detected by
western blot of cell extracts (Fig. 2B), of a non-functional CHC
(Iversen et al., 2003). As expected, a decrease in clathrin-
mediated endocytosis (Fig. 2C) was observed in these cells.
Thus, Tet− cells positive for TF fluorescence represented only a
10% of those found in Tet+ cells (Fig. 2D). This lack of
functional clathrin inhibited both FMDV and VSV internaliza-
tion, as shown in Fig. 3A. Tet− cells mostly accumulated viral
fluorescence in the plasma membrane, which appeared with a
perinuclear distribution in FMDV-infected Tet+ cells. In
addition, a reduction of 67% in the PFU recovered from Tet−
cells infected with VSV was observed and the size of the viral
plaques developed was considerably smaller (Fig. 3B). Like-
wise, the percentage of Tet− infected cells positive to G
glycoprotein fluorescence was lower (51%) than that detected in
Fig. 2. Susceptibility of Tet+ cells to FMDVand VSV infection and effect of clathrin depletion in TF uptake. (A) Growth curve of FMDVand VSV in BHK-21 and
Tet+ cells, which were infected at an MOI of 0.5. Virus titre in infection medium was determined, at different time points, by plaque assay on BHK-21 cells. The means
of two independent experiments are shown; SD values were lower than 25%. (B) Western blot with an antiserum to CHC in Tet+ and Tet− cells. Blotting to an anti-β-
actin MAb was included as control of protein loading. (C) Expression of CHC antisense RNA inhibits TF internalization. Tet+ and Tet− cells were incubated with
Alexa Fluor 488-labeled TF, as described in Materials and methods. Scale bar: 20 μm. (D) Expression of CHC antisense RNA reduces the number of cells internalizing
TF. The percentage of cells (relative to values of Tet+ cells) positive for TF fluorescence, determined as in panel C, is indicated. The means and SD from three
independent experiments are shown.
108 M.A. Martín-Acebes et al. / Virology 369 (2007) 105–118Tet+ cells (Fig. 3C). However, infection of Tet− cells with
FMDV did not result in detectable viral plaques and the low
level of VP1 fluorescence impaired a sensitive detection of
infected cells (data not shown).
To analyze virus production in Tet+ and Tet− infected cells,
total virus production was titrated in BHK-21 cells. A
significant reduction in FMDV titres (about 80%) was found
in Tet− cells, which was similar to that observed in this cells
infected with VSV (Fig. 3D).
These results confirm the direct requirement of clathrin for
productive type C FMDV internalization in these BHK-21
derived cells.
Progress of FMDV infection depends on endosomal acidification
To determine the requirement of trafficking through acidic
endosomes for FMDV infection progress, cells were incubatedwith NH4Cl, which blocks endosomal acidification and has
been shown to inhibit FMDV and VSV growth (Baxt, 1987;
Carrillo et al., 1984; Matlin et al., 1982). BHK-21 cells stained
with AO showed a vesicular pattern of red fluorescence,
corresponding to accumulation of AO in acidic endosomes. In
contrast, and confirming the increase in endosomal pH induced
by NH4Cl, when cell cultures were incubated with 25 mM
NH4Cl, a drastic reduction of red fluorescence was observed,
which was complete in cells treated with 50 mM NH4Cl (Fig.
4A, a–c). The effect of this inhibition of endosomal acidifica-
tion on FMDV infection is shown in Fig. 4A, d–f. Control cells
infected with FMDV at a high MOI showed, at 3 h PI, a VP1
fluorescence pattern distributed throughout cell cytoplasm,
corresponding to the novo VP1 synthesis, as expected from the
progress of virus infection. In contrast, infected cells treated
with NH4Cl exhibited a VP1 fluorescence that appeared with a
vesicular pattern, which resembled that observed in cells at early
Fig. 3. Expression of CHC antisense RNA inhibits FMDVand VSV internalization and infection in Tet− cells. (A) Tet+ and Tet− cells were infected with FMDVor
VSV (MOI of 35); after 25 min, cells were fixed and processed for immunofluorescence usingMAb 5C4 orMAb I1, respectively. Scale bar: 20 μm. (B) PFU recovered
from Tet+ or Tet− cells infected with 50–100 PFU of VSV. The means and SD from three independent experiments are shown (right). (C) Expression of CHC antisense
RNA reduces the number of VSV-infected cells. Tet+ or Tet− cells were infected with VSV (MOI of 0.5). At 6 h PI, cells were fixed and processed for
immunofluorescence using MAb I1. The means and SD from three independent experiments are shown. (D) Expression of CHC antisense RNA reduces FMDVand
VSV virus yield. Tet+ and Tet− cells were infected with FMDVor VSV (MOI of 0.5) and the virus yield at 9 h PI was determined by plaque assay in BHK-21 cells. The
means and SD from three independent experiments are shown. The percentages shown in panels B–D are relative to the values of Tet+ cells.
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treatment was found in FMDV-infected IBRS-2 cells (see Fig.
S2). As reported (Rigaut et al., 1991), treatment of BHK-21
cells with NH4Cl blocked VSV entry progress in a comparable
manner (Fig. 4A, g–i).
The blockage observed in virus progression correlated with a
significant decrease in the percentage of cells expressing
FMDV capsid proteins, which was reduced to values below
20% of those observed in control BHK-21 cells, being this
reduction higher in IBRS-2 cells (Fig. 4B). A significant
reduction in the VP1 protein detected by western blotting of
BHK-21 and IBRS-2-infected cell proteins was also noticed
(not shown). Likewise, the total virus yield from BHK-21
treated cells was, at least, ten-fold lower than those recovered
from control cells (Fig. 4B), and again higher reductions were
found in IBRS-2 cells. The susceptibility of VSV infection to
NH4Cl was higher and resulted in about a 4 log reduction of the
virus yield. Treatment with NH4Cl did not inhibit the virus yield
when added to the cultures 3 h PI (data not shown), ruling out
the possibility that NH4Cl significantly affects viral replication,
as reported (Baxt, 1987).
As described for type O FMDV (Berryman et al., 2005),
raise of endosomal pH by pre-treatment with concanamycin A,a specific inhibitor of V-ATPAse, inhibited FMDV and, to a
larger extent, VSV infection (see Fig. S3). These inhibitions
were lower than those exerted by NH4Cl, which could be due to
pH recovery after concanamycin A removal (see Materials and
methods). As observed with NH4Cl, concanamycin A also
induced a higher reduction in virus titers in FMDV-infected
IBRS-2 cells for which inhibitions of about 90% were observed
with 100 nM concentrations of the drug.
Thus, these results support that traffic through acidic
compartments is required for type C FMDV decapsidation
and virus replication. As expected from its higher stability to
acidic pH, this requirement was higher for VSV replication.
Requirement of acidic endosomes for FMDV infection in
Tet− cells expressing non-functional clathrin
Treatment of Tet+ cells with NH4Cl resulted in 70%
reduction of the virus recovered upon FMDV infection relative
to control Tet+ cells (Fig. 5A). Conversely, no differences in the
virus yield was found between Tet− cells, either treated or not
with NH4Cl, whose viral titers were similar to those found in
Tet+ cells treated with this compound. Amuch higher sensitivity
of VSV infection to NH4Cl was observed. Thus, a four-log
Fig. 4. Acidic pH requirement of FMDVand VSVinfection. (A) Effect of different concentrations of NH4Cl in FMDVandVSVinfection of BHK-21 cells. (a) AO staining
of control cells in which acidic organelles are stained in red and nuclei in green. (b) AO staining of cells treated 25 or (c) 50 mM NH4Cl. (d–f) NH4Cl treatment blocks
FMDV infection. After 3 h of FMDV infection (MOI of 35), cells were fixed and processed for immunofluorescence using MAb 5C4. Untreated control cells (d) and cells
treated with 25 or 50mMNH4Cl (e and f, respectively). (g–i) NH4Cl treatment blocks VSVinfection. Cells infected with VSV, as for FMDV, were fixed and processed for
immunofluorescence usingMAb I1. Scale bars: 20μm. (B)NH4Cl inhibits FMDVandVSVinfection. Cells non-treated and treatedwith 25 or 50mMNH4Clwere infected
with FMDVor VSV (MOI of 0.5). Total virus yield at 8 h PI was determined by plaque assay on BHK-21 cells. The number of infected cells expressing FMDV VP1 was
determined, at 6 h PI, by immunofluorescence usingMAb SD6, and the percentage of infected cells (relative to control untreated cells) is indicated. Themeans and SD from
three independent experiments are shown. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 5. Effect of endosomal acidification blockage of Tet+ and Tet− cells on FMDVand VSV internalization and infection. (A) Effect of NH4Cl treatment. Tet+ and
Tet− cells were treated with 25 mMNH4Cl and then infected with FMDVor VSV (MOI of 0.5). Total virus yield, at 9 h PI, was determined by plaque assay in BHK-21
cells and is presented as a percentage, relative to values of Tet+ cells. The means and SD from three independent experiments are shown. (B) Effect of concanamycin A
treatment. Tet+ and Tet− cells were treated with 1000 nM concanamycin A and total virus yield in infected cells was determined as in panel A. The means and SD from
three independent experiments are shown. (C) Time course of FMDV growth on Tet− cells treated with 1000 nM concanamycin A. Tet− cells were infected with
FMDV (MOI of 0.5) and at different times PI total virus yield was determined. The means of two independent experiments are shown; SD values were lower than 15%.
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Tet− cells, infected with VSV in the presence of NH4Cl.
These results could suggest that type C FMDVentering Tet−
cells, which lack functional clathrin exploit alternative endocy-
tic pathways that either led the virus to other compartment less
affected by the acidification blockage exerted by NH4Cl, or in
which a pH decrease is not required for viral RNA release. This
possibility was not supported by the results obtained using
concanamycin A. With this drug, a limited, but significant,
reduction in virus titer was observed at 9 h PI for Tet+ and Tet−
cells (Fig. 5B). For Tet− cells, a limited increase with time in
virus titer was observed, while such increase was not detectable,
at different hours post-infection, in Tet− cells treated with
concanamycin A (Fig. 5C). Thus, our results suggest that
FMDV multiplication in Tet− cells requires acidic endosomes.
BHK-21 and IBRS-2 cells express caveolin-1
To evaluate whether caveola-mediated endocytosis could
contribute to FMDV internalization, we first analyzed the
expression of caveolin-1 in BHK-21 and IBRS-2 cells. Fig. 6A
shows a western blot of cell extracts of BHK-21 and IBRS-2.The rabbit polyclonal antibody anti-caveolin 1 used showed that
both cell lines expressed caveolin-1, being the level of
expression detected higher in BHK-21 cells. As reported
(Millan et al., 1997), no caveolin-1 expression was detected
in Jurkat cells, used as control. Fig. 6B shows the immuno-
fluorescence pattern of caveolin-1 in IBRS-2, which appeared
as membrane-associated vesicles, corresponding to lipid-rafts
and caveolae, as well as with a perinuclear distribution
characteristic of a Golgi location, as reported (Kurzchalia et
al., 1994). Similar results were obtained using BHK-21 cells
(data not shown).
Role of cholesterol in FMDV endocytosis and virus production
Since BHK-21 and IBRS-2 cells express caveolin-1, we
explored the effect on FMDV entry of drug treatments
interfering with caveola-mediated endocytosis. Cholesterol is
an important component of lipid-rafts, which are involved in
caveola formation. Thus, we analyzed the effect on FMDVentry
and infection progress of the cholesterol-sequestering com-
pound nystatin that selectively disrupts membrane lipid-rafts,
including those required for caveolae formation (Chen and
Fig. 6. Caveolin-1 expression in BHK-21 and IBRS-2 cells. (A) Western blot of
BHK-21 and IBRS-2 cell extracts with anti-caveolin 1 antibody. Extracts of
Jurkat cells that do not express caveolin-1 were included as control. Blotting to
an anti-β-actin MAb was included as control of protein loading. (B)
Immunofluorescence of IBRS-2 cells incubated with anti-caveolin 1 antibody
and an Alexa Fluor 488-labeled secondary antibody. Scale bar: 20 μm.
112 M.A. Martín-Acebes et al. / Virology 369 (2007) 105–118Norkin, 1999), and of MβCD that depletes cholesterol from cell
membranes (Sieczkarski and Whittaker, 2002a; Simons and
Ikonen, 1997). A pre-treatment of cells with 25 μg/ml of
nystatin for 1 h (70% and 82% cell viability for BHK-21 and
IBRS-2, respectively) was chosen for these experiments.
Fig. 7A shows that the internalization of labeled CTX, a lipid
raft-ligand that can use different endocytic mechanisms
(Torgersen et al., 2001), including a non-clathrin, non-caveolae
pathway (Chinnapen et al., 2007), was, as expected, reduced in
BHK-21 cells by the treatment with nystatin. Nevertheless, no
effect was observed in the internalization of either FMDV or
labeled TF (Fig. 7A).
Treatment of BHK-21 cells with 10 mMMβCD resulted in a
severe depletion of the cholesterol at the cell membrane, as
estimated by cell staining with the cholesterol-binding drug
filipin. As reported (Keller and Simons, 1998), this treatment
did not significantly alter the cholesterol found in intracellular
membranes. A clear inhibition of CTX uptake was found in
cells treated with MβCD. A similar effect was noticed in theFig. 7. Role of cholesterol in FMDVentry and infection. (A) Effect of MβCD and nys
25 μg/ml of nystatin were incubated with Alexa Fluor 594-labeled CTX, Alexa Fluor
immunofluorescence staining of VP1 using MAb 5C4 and an Alexa Fluor 488 sec
analyzed by filipin staining. Scale bars: 20 μm. (B) Analysis of virus infection after M
in panel A, were infected with either FMDVor VSV (MOI of 0.5). At 8 h PI, total viru
cells expressing FMDV VP1 was determined, at 6 h PI, by immunofluorescence usin
those observed in untreated control cells. The means and SD from three independeninternalization of FMDV, whose virions were preferentially
detected at the surface of infected cells treated with MβCD (Fig.
7A). Similar results were observed in IBRS-2 cells treated with
MβCD (Fig. S4). Uptake of TF was also affected by the MβCD
treatment, confirming the requirement of cholesterol in the
clathrin-mediated endocytosis, as previously reported (Rodal
et al., 1999).
Then, we studied the effect of nystatin and MβCD on post-
entry steps of viral cycle leading to productive infection. In fact,
the results obtained with BHK-21 and IBRS-2 cells showed a
good correlation with those observed on viral internalization.
Thus, relative to control cells, no significant reductions in the
percentage of infected cells expressing capsid protein VP1, or in
the virus yield recovered from infected cultures treated with
nystatin, were noticed (Fig. 7B). This lack of effect on the virus
yield was also observed for VSV-infected cells. Conversely,
depletion of cholesterol with MβCD in the two cell lines
studied, resulted in a significant reduction of the FMDV-
infected cells, which showed values of 63% and 40% for BHK-
21 and IBRS-2, respectively. Similar reductions were observed
in the virus production, which paralleled that found in VSV-
infected cells (Fig. 7B).
Thus, while the reorganization of cholesterol induced by
nystatin does not affect type C FMDV entry and progression,
depletion of cholesterol from plasma membranes by MβCD
decreases FMDV internalization and virus infection.
Discussion
Viruses that enter host cells by endocytosis are becoming
interesting tools in studies of membrane traffic in animal cells.
Recently, they have been used to characterize novel endocytic
mechanisms that bypass the classical clathrin-mediated uptake
processes (Damm et al., 2005; Pietiainen et al., 2004). The type
C FMDV used in our study mainly enters established cell lines
derived from porcine (IBRS-2) and hamster (BHK-21) cells by
using a clathrin-dependent endocytosis, as indicated by uptake
blockage of FMDV particles observed in immunofluorescence
assays upon sucrose treatment. This blockage affects also the
progression of virus infection, as indicated by the reductions in
infected cells and virus yield in infections performed at low
MOI to limit productive vital entries that could exploit pathways
other than those more efficiently used by FMDV. These results
extends previous observations on the entry requirements of
FMDV isolates from different serotypes in cells expressing
human αvβ3 and αvβ6 integrins (Berryman et al., 2005;
O'Donnell et al., 2005), to the productive infection by serotype
C FMDV of two widely used cell lines.
IBRS-2 cells express αvβ8 integrin (Burman et al., 2006),
while BHK-21 have been reported to express αvβ3 (Chu andtatin on endocytosis pathways. BHK-21 cells treated with 10 mMMβCD or with
488 TF or infected with FMDV (MOI of 35) for 25 min, fixed and processed for
ondary antibody. Control of cholesterol depletion after MβCD treatment was
βCD or nystatin treatment. Cells, incubated with nystatin or MβCD as described
s yield was determined by plaque assay on BHK-21 cells. The number of infected
g MAb SD6. The percentages of virus titers and of infected cells are relative to
t experiments are shown.
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sequence identity in the capsid proteins to that published for the
original isolate, which infected cultured cells via integrinsreceptors (Baranowski et al., 1998; Jackson et al., 2000). These,
rule out the possibility of selection, during virus amplification,
of the mutation reported to confer type C FMDV the capacity to
114 M.A. Martín-Acebes et al. / Virology 369 (2007) 105–118enter cultured cells via heparan sulphate (Baranowski et al.,
1998). Since αv integrins have been shown to be internalized
into clathrin-coated pits and subsequently transferred to early
endosomes (Berryman et al., 2005; Upla et al., 2004), the
results reported here likely correspond to type C FMDV
integrin-mediated entry and progression in BHK-21 and IBRS-
2 cells. The lack of MAbs efficiently recognizing the integrins
expressed in these cell lines (O'Donnell et al., 2005) has
impaired the inclusion in our study of data from integrin
internalization. We cannot exclude that the inhibition of
clathrin-dependent endocytosis could alter expression of virus
receptors at the cell surface leading to reduced virus binding
and infection and this could contribute to the inhibitory effects
found. However, FMDVappears attached at the cell membrane
in cells treated with sucrose in our experiments as well as in
those reported by (Berryman et al., 2005), suggesting that a
major alteration in the expression of intergrins does not occur
upon sucrose treatment. On the other hand, transferrin receptor
(another ligand taken in by clathrin-dependent endocytosis),
which co-localizes in the same endosomes with FMDV and its
αvβ6 receptor (Berryman et al., 2005; O'Donnell et al., 2005),
rather than being depleted, accumulates in the membrane
surface of Tet− cells (Iversen et al., 2003). These results
suggest that the inhibitions observed are mostly due to
inhibition of uptake of surface-bound viruses from clathrin
coated pits.
Interestingly, the results obtained with BHK21-tTA/anti-
CHC show a direct, functional requirement of clathrin (CHC)
for FMDV entry and multiplication. The dependence on CHC
for infection of viruses using clathrin-mediated endocytosis has
been previously reported utilizing different strategies. (Pelk-
mans et al., 2005; Sun et al., 2005; Wettey et al., 2002).
However, to our knowledge, this is the first study that has
utilized an inducible cell line against CHC for virus entry
characterization. Other inducible cell lines, such as those
expressing dominant negative forms of dynamin, have been
revealed as valuable tools to uncover the entry route of different
viruses (Chung et al., 2005; DeTulleo and Kirchhausen, 1998;
Snyers et al., 2003). However, the negative mutant of dynamin
can inhibit several types of endocytosis. It inhibits uptake from
caveolae (Oh et al., 1998) as well as clathrin- and caveolae-
independent endocytosis that can be dependent on dynamin
(Lamaze et al., 2001).
In our experiments (Fig. 3D), a residual level of FMDV
infection was observed when clathrin-mediated endocytosis
was blocked by tetracycline removal in Tet− cells. Despite
the low virus yield recovered from infected Tet− cells, no
additive effect on this inhibition was observed upon NH4Cl
treatment, (Fig. 5A), while a reduction was observed in cells
treated with concanamycin A (Figs. 5B, C). These
observations suggest that type C FMDV entry in these
cells, which lack functional clathrin, could exploit alternative
endocytic pathways that led the virus to acidic compart-
ments where viral RNA is released. Transit through early
acidic endosomes for productive internalization can use
endocytic pathways other than the clathrin-mediated, as
reported for Influenza virus (Sieczkarski and Whittaker,2002b) and diphtheria toxin (Skretting et al., 1999).
However, we cannot exclude that the FMDV infection
observed when clathrin is blocked could be due to some
“leakiness” in the system rather than a true clathrin-in-
dependent entry phenomenon. In any case, further experi-
ments are required to confirm this possibility.
The expression of caveolin-1 by BHK-21 and IBRS-2 cells
has also allowed the analysis of the potential contribution of
the caveolae-mediated internalization pathway in FMDV
entry. As cholesterol is an important component of lipid-
rafts, which are involved in caveolae formation, we analyzed
the effect on FMDV entry and infection of nystatin, a sterol-
binding drug that sequesters cholesterol, and of MβCD that
depletes cholesterol from membranes (Sieczkarski and Whit-
taker, 2002a). The results obtained support that FMDV
endocytosis in BHK-21 and IBRS-2 cells is not affected by
the lack of lipid-rafts integrity reported to be induced by
nystatin (Chen and Norkin, 1999) but depends on the
presence of certain levels of cholesterol in the plasma
membrane, probably as this molecule seems to be required
for the formation of clathrin-coated vesicles (Rodal et al.,
1999; Subtil et al., 1999), for the regulation of downstream
stages (Peres et al., 2003) and for recruitment of clathrin
vesicles machinery (Urs et al., 2005). Indeed, extraction of
plasma membrane cholesterol with MβCD has been shown to
inhibit clathrin-mediated endocytosis of human rhinovirus
(Snyers et al., 2003) and a requirement of cholesterol, but not
of lipids-rafts, has also been recently reported for poliovirus
cell entry (Danthi and Chow, 2004). Previous studies,
performed with a lower concentration of MβCD than that
used in this study, showed that infection of SW480-αvβ6 cells
with type O FMDV was not affected by MβCD treatment
(Berryman et al., 2005). This discrepancy could be due to the
different susceptibility to the drug of the cell types used, as
reported in other viral models (Gilbert and Benjamin, 2000;
Richterova et al., 2001).
Interestingly, the differences in the sensitivity to endosomal
acidification inhibition by NH4Cl or concanamycin A (Fig. 4
and Fig. S3) suggest that FMDV and VSV may uncoat into
different classes of endosomes. Supporting this idea, VSV has
been shown to deliver its genetic material to cytoplasm from
late endosomes (Le Blanc et al., 2005), whereas FMDV has
never been found in late endosomes or lysosomes (Berryman et
al., 2005; O'Donnell et al., 2005). These differences in
intracellular trafficking may reflect differential sorting from
distinct populations of clathrin-coated pits involved in FMDV
and VSV internalization. Such differences have been described
for other ligands of the clathrin endocytic pathway that are
sorted to populations of early endosomes that either maturate
rapidly toward late endosomes, or that maturate much more
slowly (Lakadamyali et al., 2006). However, these differences
could not be revealed by treatments directly targeted to clathrin-
coated pit endocytosis, as CHC depletion. These findings show
the usefulness of performing comparative studies with different
viruses in order to study in depth the multiple viral internaliza-
tion pathways (Damm and Pelkmans, 2006; Pelkmans et al.,
2005).
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Cells and viruses
BHK-21 cells (ATCC) and IBRS-2 (c-26) cells were grown
in Dulbecco's modified Eagle's medium (DMEM) supplemen-
ted with 5% fetal calf serum (FCS) (Gibco), penicillin (100 U/
ml), streptomycin (100 μg/ml) and 20 mM L-glutamine.
BHK21-tTA/anti-CHC cells (Iversen et al., 2003) were main-
tained in select DMEM supplemented with 10% FCS, 200 μg/
ml geneticin (Gibco), 0.5 μg/ml puromycin (Sigma) and 2 μg/
ml tetracycline (Sigma). For induction of CHC anti-sense RNA
expression, cells were grown in select DMEM and tetracycline
was removed 72 h prior to the experiments. FMDV isolate C-
S8c1, a derivative of a type C field virus isolated in Santa Pau
(Spain, 1970) by triple plaque purification (Sobrino et al.,
1983), and VSV (Indiana serotype) were used in this study.
Viral stocks were prepared by infecting at a multiplicity of
infection (MOI) – defined as the plaque forming units of virus
(PFU)/cell – of about 1, monolayers of BHK-21 cells, as
described below. Viral RNA from C-S8c1 stock was amplified
by RTR-PCR and used to determine the nucleotide sequences
corresponding to the capsid proteins, as described (Nunez et al.,
2001); the sequences obtained were as previously published
(Toja et al., 1999).
Antibodies and reagents
FMDV VP1 and VSV G protein were detected using
monoclonal antibodies (MAb) SD6 or 5C4 (Lea et al., 1994;
Mateu et al., 1987) and MAb I1 (Lefrancois and Lyles, 1982),
respectively. Rabbit polyclonal antibodies were used to detect
caveolin-1 (BD Transduction Laboratories) and clathrin heavy
chain (Sta. Cruz Biotechnology). MAb anti-β-actin AC-15 was
from Sigma. Sheep anti-mouse IgG and donkey anti-rabbit IgG
coupled to horseradish peroxidase were from Amersham. Goat
anti-mouse IgG Alexa Fluor 488 or 594 labeled, as well as
transferrin (TF) and cholera toxin (CTX) conjugated to Alexa
Fluor 488 or 594, respectively, were from Molecular Probes.
Nystatin, filipin III, methyl-β-cyclodextrin (MβCD), concana-
mycin A and bovine serum albumin (BSA) were purchased
from Sigma. Sucrose and NH4Cl were from Merck. Nystatin,
filipin and concanamycin A were prepared in DMSO as 5 mg/
ml, 2.5 mg/ml and 28.8 μM stock solutions, respectively.
NH4Cl (1 M) was dissolved in water and the rest of chemicals
were directly prepared in DMEM.
Drug treatments
For endocytosis inhibition, cells grown on tissue culture
plates or coverslips, were washed twice with DMEM and
incubated with the corresponding drug for the appropriate time.
Control cells were incubated in the same conditions in DMEM
containing the solvent concentration used for each drug. To test
the role of lipid-rafts and cholesterol in endocytosis, cells were
pre-treated for 1 h with a nystatin concentration (25 μg/ml),
which was selected after a viability assay, or by treatment withMβCD (10 mM) for 30 min, as previously reported (Keller and
Simons, 1998). Nystatin was maintained during the whole
infection period while MβCD was present only during pre-
treatment. The role of clathrin in endocytosis was tested by a
hypertonic shock induced by treating cells for 30 min with
0.45 M sucrose in DMEM before FMDV infection or
fluorescent TF incubation, the later as control of the clathrin
pathway impairment. To avoid cellular recovery, sucrose was
maintained during the first hour of infection or during the TF
internalization time. The lysosomotropic agent NH4Cl was used
to block endosomal acidification. Cells were pre-treated for 1 h
with 25 or 50 mM NH4Cl in DMEM with 25 mM HEPES pH
7.4 and the drug was maintained during the whole infection
period to avoid cellular recovery. For concanamycin A
treatment, cells were pre-treated 30 min and the drug was
maintained during the first hour of infection, as reported
(Berryman et al., 2005).
Infections and virus titration
Cells grown on coverslips or tissue culture plates were
infected at different MOI with virus diluted in DMEM. After 1 h
of adsorption, the inoculum was removed and fresh medium
containing 5% FCS was added. Virus yield was determined by
plaque assay on BHK-21 cell monolayers, as described
(Sobrino et al., 1983). Briefly, cells were adsorbed with
infection medium samples, the inoculum removed after 1 h
and the infection allowed to proceed for 24 h in semisolid
medium (0.5% agar, 1% FCS and 0.045 mg/ml DEAE-Dextran
in DMEM) to determine virus titers (PFU/ml). Finally, the cells
were fixed and stained with 0.3% crystal violet in 2%
formaldehyde. To determine total virus production (intracellular
and infection medium), plates were subjected to three freeze–
thaw cycles and the virus titer determined as described above.
When performing infections for western blot analyses or to
determine FMDV virus yield after endocytosis inhibition,
extracellular virions were acid inactivated after the first hour of
infection by washing with PBS pH 6.0, followed by two washes
with DMEM to neutralize extracellular pH. For plaque
reduction assays, cell monolayers were infected with 50–100
viral PFU, and the PFU developed in semisolid medium were
quantified as described above.
Transferrin and cholera toxin internalization
For TF endocytosis assays, cells grown on coverslips, were
washed twice with DMEM and were incubated with 10 μg/ml
TF-Alexa Fluor 488 prepared in DMEM containing 0.5% BSA.
After 5 min of internalization at 37 °C, cells were washed with
200 mM acetic acid and 200 mM NaCl and sequentially with
150 mM NaCl, 20 mM HEPES pH 7.4, 10 mM glucose, 5 mM
KCl, 1 mM MgCl2 and 1 mM CaCl2 to eliminate extracellular
TF (Lukacs et al., 1997). Finally, the cells were washed twice
with PBS and fixed in 4% paraformaldehyde in PBS. In the case
of CTX endocytosis assays, cells were incubated 30 min with
CTX-Alexa Fluor 594 (8 μg/ml) in DMEM containing 0.5%
BSA, washed twice with PBS and fixed. Aldehyde fluorescence
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Immunofluorescence
Cells grown on coverslips were washed twice with PBS and
fixed with 4% paraformaldehyde in PBS for 20 min, washed
with PBS and permeabilized with BPTG (1% BSA, 0.1%
Triton-X 100, 1 M glycine in PBS) for 15 min at room
temperature (RT). Primary antibodies prepared in 1% BSA in
PBS were incubated for 1 h at RT. Cells were washed with PBS,
stained with the corresponding fluorescent antibody for 30 min
at RT and then washed with PBS. Cell nuclei were counter-
stained with 1 μg/ml DAPI (4′,6-diamidino-2-phenylindole) in
PBS for 5 min, rinsed with PBS and mounted in Fluoromount G
(Southern Biotech Assoc., USA). Samples were observed using
an Olympus BX61 epi-fluorescence microscope coupled to a
digital camera DP70 (Olympus). Images were acquired using
Olympus DP controller software and processed using Adobe
Photoshop 7.0 (Adobe Systems Inc.).
Detection of infected cells
Monolayers of BHK-21 or IBRS-2 cells grown on glass
coverslips were infected, fixed at 6 h post-infection (PI) and
processed for immunofluorescence using MAbs SD6 and I1 to
detect FMDV or VSV, respectively. For quantification of
infected cells, a minimum of 300 cells per coverslip were
scored (three coverslips).
Acridine orange vital staining
Fluorescent labeling of acidic organelles was performed
using acridine orange (AO) vital staining, as reported (Al-
Younes et al., 1999). AO fluorescence is red when it
protonates and accumulates in acidic vesicles. Briefly, cells
treated with NH4Cl as described above were incubated in
fresh medium, containing or not NH4Cl and 5 μg/ml AO for
10 min at 37 °C, washed three times with the same media
without AO and observed under fluorescence microscope
using a filter set that permits simultaneous observation of
green and red fluorescence.
Filipin staining
Cholesterol levels in cells treated with MβCD were
estimated by filipin staining, as previously described (Keller
and Simons, 1998). Briefly, cells were fixed on ice in 4%
paraformaldehyde, stained 15 min at RT with 125 μg/ml filipin
in PBS, washed twice with PBS for 15 min and mounted in
Fluoromount G.
Western blot
Cells were lysed on ice in lysis buffer (10 mM EGTA,
2.5 mM MgCl2, 1% NP-40, 20 mM HEPES pH 7.4), collected
with a cell scraper and sonicated. Equal amounts of protein,estimated by Bradford, were mixed with Laemmli sample
buffer. After SDS–PAGE electrophoresis proteins were trans-
ferred onto nitrocellulose membranes and incubated with
specific antibodies, then with HRP-coupled anti-mouse or
anti-rabbit antibodies and subsequently developed using
western lighting chemiluminescence reagent (Perkin Elmer),
as described (Garcia-Briones et al., 2006). Relative CHC levels
were determined by image analysis using a Typhoon 9410
scanner and ImageQuant TL software (Amersham).
Data analysis
Analysis of the variance (ANOVA) using F Fischer–
Snedecor distribution was performed with statistical package
SPSS v.12 (SPSS Inc.) for Windows. Differences were
considered statistically significant at pb0.05 and are indicated
by an asterisk in the figures.
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